A carregar...
Midostaurin In Acute Myeloid Leukemia: An Evidence-Based Review And Patient Selection
Fms-related-tyrosine kinase 3 (FLT3) mutations occur in approximately a third of acute myeloid leukemia (AML) patients and confer an adverse prognosis. Numerous studies have evaluated FLT3 targeting as single agent and in combination approaches in frontline and relapsed AML. At this time, midostauri...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6782026/ https://ncbi.nlm.nih.gov/pubmed/31632141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S177894 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|